Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human tumor testsystems: a new screening approach.

H P Kraemer, H H Sedlacek

    Behring Institute Mitteilungen
    |June 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A Novel Magnetic Field Device for Inducing Hyperthermia Using Magnetic Nanoparticles.

    Biomedizinische Technik. Biomedical engineering·2013
    Same author

    Mechanisms of action of flavopiridol.

    Critical reviews in oncology/hematology·2001
    Same author

    Pharmacological aspects of targeting cancer gene therapy to endothelial cells.

    Critical reviews in oncology/hematology·2001
    Same author

    Kinase inhibitors in cancer therapy: a look ahead.

    Drugs·2000
    Same author

    Secreted human beta-glucuronidase: a novel tool for gene-directed enzyme prodrug therapy.

    Gene therapy·2000
    Same author

    Elevated expression of endoglin, a component of the TGF-beta-receptor complex, correlates with proliferation of tumor endothelial cells.

    International journal of cancer·1999
    Same journal

    Clinical Experience with ALG.

    Behring Institute Mitteilungen·2010
    Same journal

    Production of a Standardized Anti-Lymphocyte Globulin.

    Behring Institute Mitteilungen·2010
    Same journal

    Immunosuppression and Neoplasia.

    Behring Institute Mitteilungen·2010
    Same journal

    Molecular and Immunological Aspects of Host-Parasite Interactions. Symposium proceedings. Wurzburg, Germany, June 6-8, 1996.

    Behring Institute Mitteilungen·1997
    Same journal

    The galactose-inhibitable surface lectin of Entamoeba histolytica, a possible candidate for a subunit vaccine to prevent amoebiasis.

    Behring Institute Mitteilungen·1997
    Same journal

    Plasmodium vivax: epitope mapping of monoclonal antibodies against the N-terminal region of the merozoite surface protein 1.

    Behring Institute Mitteilungen·1997
    See all related articles

    A novel human tumor screening system demonstrates predictive value for new anti-cancer drugs. This system utilizes diverse human tumor models, outperforming traditional NCI screening for certain therapeutics.

    Area of Science:

    • Oncology
    • Pharmacology
    • Translational Medicine

    Background:

    • Traditional cancer drug screening often relies on animal models, which may not accurately reflect human tumor responses.
    • Tumor heterogeneity and the preselection of fast-proliferating tumors can limit the effectiveness of current screening systems.
    • There is a need for more predictive preclinical models to identify effective anti-cancer agents for human use.

    Purpose of the Study:

    • To introduce and evaluate a novel screening system based on human tumor material for assessing potential anti-cancer drug efficacy.
    • To address limitations of existing screening methods, including tumor heterogeneity and preselection bias.
    • To identify drugs that show preferential activity in human tumor models compared to standard NCI screening.

    Main Methods:

    Related Experiment Videos

    • Utilized various in vitro and in vivo test systems, including the human tumor clonogenic assay, subrenal capsule assay, and human tumor xenograft models.
    • Established a broad panel of slow-proliferating human tumors in nude mice to allow for repeated testing and overcome tumor heterogeneity.
    • Evaluated the predictive value of the system through correlations with clinical activity in retrospective and prospective trials.

    Main Results:

    • The human tumor-based screening system demonstrated predictive value, showing reasonable correlation between test results and clinical activity.
    • This system successfully identified certain drugs that were preferentially active against human tumors.
    • These identified drugs showed only marginal activity in the standard National Cancer Institute (NCI) animal tumor screening system.

    Conclusions:

    • The developed human tumor-based screening system offers a more predictive platform for evaluating anti-cancer drug effectiveness.
    • This approach helps overcome challenges associated with tumor heterogeneity and fast-proliferating tumor bias in drug selection.
    • The system holds promise for identifying novel therapeutics with improved clinical efficacy compared to those found through traditional screening methods.